The Idolbuster

JANUARY 15, 2013

I heard a cautionary tale from “George” the former VP of marketing at a mid-sized biotechnology company about how a bogus forecast helped propagate a disaster. It is tempting to think that these numbers are scientifically derived and reliable, but often they come from sticking a finger in the air, and then justified after-the-fact in Excel.

Biotechnology 41

Biotechnology Groupthink CFO Stress 41

Strategy Driven

MAY 12, 2021

Drug Research —The applications for drug design and biotechnology using 3D displays can be exponential. Peruvemba is also a right arm off-spinner for a cricket team he co-founded in Silicon Valley. One new 3D display has a resolution of 100 million volume pixels or “voxels.”

Technology 104

Technology Content Video Globalization 104

Skip Prichard

JULY 22, 2019

When Edison and his team invented the phonograph, he immediately took it to the editor of Scientific American to show it off. Unfortunately, many of us have developed expertise in only one field (software engineering, information technology [IT], marketing, biotechnology, automobile manufacturing, the food industry, etc.

Innovation 80

Innovation Social Capital Reputation How To 80

Harvard Business Review

MAY 7, 2018

But sometimes you need to get into a meeting, perhaps because the decisions made there will have implications for you or your team, or maybe because you feel you’ve been left out of important discussions. Will you or your team be significantly affected by the outcome? You and Your Team Series. Roger Schwarz.

Restructuring 13

Restructuring How To Compliance Biotechnology 13

Harvard Business Review

JULY 11, 2018

Our team analyzed the age of all business founders in the U.S. However, young people are less common in other industries such as oil and gas or biotechnology, where the average age is closer to 47. ” But is this view correct? Debunking the Myth of the Young Entrepreneur. Census Bureau.

Succession 15

Succession IPO Entrepreneur Biotechnology 15

Harvard Business Review

NOVEMBER 15, 2016

In contrast, New England has increasingly become a hub for ventures in life sciences; the first three-quarters of 2016 saw almost 60% of VC investments in New England go to ventures in biotechnology and medical devices. Lured by Silicon Valley’s ability to help the company scale up faster, he and his team moved to the Bay Area.

Biotechnology 8

Biotechnology Drucker Software Entrepreneur 8

Harvard Business Review

MARCH 11, 2014

Start-up companies tend to cluster in industries favored by venture capitalists (like biotechnology or information technology) or ones where there are relatively low barriers to entry (like restaurants). But how could the team get its Embrace Infant Warmer into the hands of all the hospitals and patients that needed it?

Innovation 8

Innovation Venture Capitalist Company Supply Chain 8

Harvard Business Review

FEBRUARY 17, 2011

The reason for the interest in in part because the industry has suffered from poor returns on investment over the last decade; indeed, some sectors, including biotechnology, report negative aggregate returns. In effect, the VCs at Nadathur Holdings serve as the executive team for a miniature healthcare innovation ecosystem.

Marketing 15

Marketing Venture Capitalist Biotechnology IPO 15

Harvard Business Review

SEPTEMBER 21, 2018

Some might even want to consider increasing their membership to ensure that they have the skills they need as a team and that they represent a wide enough array of perspectives. pharmaceuticals, biotechnology & life sciences, health care equipment and services); Industrials (e.g.,

Innovation 11

Innovation Short-term Telecommunications Long-term 11

Harvard Business Review

MAY 1, 2014

I learned this while leading a turnaround of NPS Pharmaceuticals , a biotechnology company that now specializes in creating treatments for rare diseases. Even individuals on NPS’s leadership team who didn’t embrace our values had to go. To save the 20-year-old company, I had to get it operating like a start-up.

Company 9

Company Pharmaceuticals Biotechnology Short-term 9

Harvard Business Review

FEBRUARY 22, 2013

Having observed management teams for decades as a mutual fund and portfolio manager, I have watched numerous companies vanish after a disastrous launch of a product or service. Cephalon's IPO was in 1991, part of the second wave of biotechnology companies to sell shares to the public. What do you do next? But Baldino didn't stop there.

Productivity 8

Productivity Products Biotechnology IPO 8

Harvard Business Review

DECEMBER 30, 2011

That was the question Todd Pierce asked himself in 2006 after years of experimenting with the full menu of trainings, meetings, and competency models in his capacity as CIO of biotechnology giant Genentech. Weiss and her team were careful to keep the language of specific belief systems and religions out of PEP.

Development 18

Development Biotechnology CIO Short-term 18

Harvard Business Review

JULY 16, 2013

He appointed a special team to create an objective, transparent method for selecting the directors. After reviewing the roles and responsibilities of each board and the natures of the new businesses, the team derived lists of the skills each board needed. oil, gas & consumable fuels, electric, gas and water utilities); Financials (e.g.,

Telecommunications 8

Telecommunications Biotechnology Health Care Real Estate 8

Harvard Business Review

OCTOBER 22, 2013

This industry is fueled by advances in chemistry and biotechnology that allow the use of pharmacological and cosmetic therapies in areas where, earlier, surgical intervention was needed. By practicing these skills, your team will improve critical and creative thinking skills, leading to many game?changing

Skills 8

Skills Power Six Sigma Disruptive Innovation 8

Tanveer Naseer

OCTOBER 20, 2015

The first leader was someone I worked with as part of the management team at a biotechnology firm, and how he guided our organization during the merger of our North American parent company with a much larger European multinational.

Power 100

Power Long-term Uncertainty Biotechnology 100

Harvard Business Review

SEPTEMBER 14, 2011

Chirotech specializes in biocatalysis and chemocatalysis, two important subspecialties of biotechnology and chemistry that help develop key biological and chemical intermediates needed for the efficient production of medicines. facility in Cambridge Science Park. Decentralize and empower global R&D units.

Globalization 10

Globalization Innovation Decentralization Chemicals 10

Harvard Business Review

OCTOBER 16, 2013

If you look at the last 20 years or so, venture capitalists did help make the Internet possible, did help make biotechnology possible, are driving a lot of investment in energy technologies and transportation technologies and government services and educational services and healthcare and so forth. I think venture capitalists do play a role.

Venture Capitalist 10

Venture Capitalist Company Biotechnology Transportation 10

Harvard Business Review

JUNE 16, 2016

.” His organization is trying to change that by reaching out to all areas of the ecosystem — “we include academic institutions, venture capitalists, and industrial players ranging from big pharma to startup biotechnology firms because we believe that the best science happens when we get everybody’s perspective, Depinho says.”

Technology 8

Technology Venture Capitalist Supply Chain Innovation 8

Harvard Business Review

FEBRUARY 19, 2015

“If others have flexibility for personal reasons” — say they coach their daughter’s soccer team, they take guitar lessons, or they are writing a book — “you may be able to have flexibility to pursue a vocational passion, too.” “I knew I wanted to be free to make these big decisions.”

Project 8

Project Outsourcing Learning-by-Doing Commitment 8

Harvard Business Review

FEBRUARY 3, 2015

The sidebar “Why We Need Fresh Blood” explains how diversity on any team often produces the best results. Why We Need Fresh Blood Stefan Wuchty, Benjamin Jones, and Brian Uzzi, a multidisciplinary team of researchers, decided to use big data to learn what distin­guished ideas that had impact from those that didn’t.

How To 8

How To Diversity Letter Learning-by-Doing 8

Harvard Business Review

MARCH 30, 2017

Looking at the executive teams we work with as consultants and those we teach in the classroom, increased diversity of gender, ethnicity, and age is apparent. Received wisdom is that the more diverse the teams in terms of age, ethnicity, and gender, the more creative and productive they are likely to be. Intuitively, this makes sense.

Diversity 8

Diversity Team Biotechnology Execution 8

Harvard Business Review

NOVEMBER 29, 2016

It has been aggressively recruiting and developing people with the requisite skills, partnering with universities and firms such as The Data Incubator to recruit and train data scientists, and it now has an entrepreneurial global team of more than 80.

Pharmaceuticals 8

Pharmaceuticals Incubator Health Care Biotechnology 8

Harvard Business Review

JANUARY 11, 2017

Take the decision of Sam Waksal, the former CEO of the emerging biotechnology company ImClone Systems. You and Your Team Series. In late 2001 ImClone awaited approval from the Food and Drug Administration (FDA) of its much-heralded new cancer treatment, but unexpectedly the FDA decided to reject the company’s application.

Ethics 8

Ethics Training Biotechnology Morale 8

Harvard Business Review

APRIL 19, 2016

In virtually every advanced field, whether it’s information technology, biotechnology, agriculture, or renewable energy, America holds a leading position. vincent tsui FOR HBR. Since World War II, the U.S. has been an innovation superpower. Other nations may challenge in one field or another, but no one can match its depth and breadth.

Innovation 8

Innovation Company Competitive Advantage Venture Funding 8

Harvard Business Review

JULY 22, 2015

“I have some news,” David Lee told his team member Mark Brown. ” Hanguk was a large, fast-growing company with diversified interests spanning electronics, biotechnology, shipping, construction, and chemicals. We pride ourselves on being a multinational leadership team. Andrew Nguyen/HBR STAFF. “Good news?”

Case Study 8

Case Study Career Biotechnology Course 8

Harvard Business Review

SEPTEMBER 11, 2014

For example, a wide variety of clean technologies (including wind, solar, and hydrogen) are vying to power vehicles and cities at the same time that a wide variety of medical technologies (chemical, biotechnological, genomic, and robotic) are being developed to treat diseases. Consider the 2×2 matrix below.

Uncertainty 22

Uncertainty Industry Bottom-up Technology 22

Harvard Business Review

AUGUST 23, 2016

More Republicans consider themselves to be very good at negotiation, while more Democrats consider themselves to be very good at building teams. pharmaceuticals, biotechnology & life sciences, health care equipment and services); Industrials (e.g., Overall, directors from both sides are bringing diverse strengths to the table.

Politics 8

Politics Committee Telecommunications Diversity 8